The importance of cognitive ageing for understanding dementia

A third of those over 80 years of age are likely to have dementia, the lack of a cure requires efforts directed at prevention and delaying the age of onset. We argue here for the importance of understanding the cognitive ageing process, seen as the decline in various cognitive functions from adulthood to old age. The impact of age on cognitive function is heterogeneous and the identification of risk factors associated with adverse cognitive ageing profiles would allow well-targeted interventions, behavioural or pharmacological, to delay and reduce the population burden of dementia. A shift away from binary outcomes such as dementia assessed at one point in time in elderly populations to research on cognitive ageing using repeated measures of cognitive function and starting earlier in the life course would allow the sources of variability in ageing to be better understood.

[1]  Yaakov Stern,et al.  Cognitive Reserve: Implications for Assessment and Intervention , 2013, Folia Phoniatrica et Logopaedica.

[2]  D. Gustafson.  Adiposity indices and dementia , 2006, The Lancet Neurology.

[3]  J. Schneider,et al.  Education modifies the relation of AD pathology to level of cognitive function in older persons , 2003, Neurology.

[4]  K Johansson,et al.  Heritability for Alzheimer's disease: the study of dementia in Swedish twins. , 1997, The journals of gerontology. Series A, Biological sciences and medical sciences.

[5]  J. Price,et al.  Mild cognitive impairment represents early-stage Alzheimer disease. , 2001, Archives of neurology.

[6]  K. Anstey,et al.  Demographic, health, cognitive, and sensory variables as predictors of mortality in very old adults. , 2001, Psychology and aging.

[7]  R. Voelker.  Guideline: dementia drugs' benefits uncertain. , 2008, JAMA.

[8]  Henrik Zetterberg,et al.  Alzheimer's disease , 2006, The Lancet.

[9]  F. Grodstein,et al.  Effects of moderate alcohol consumption on cognitive function in women. , 2005, The New England journal of medicine.

[10]  C. Brayne.  The elephant in the room — healthy brains in later life, epidemiology and public health , 2007, Nature Reviews Neuroscience.

[11]  Simon Lovestone,et al.  The dementias , 2002, The Lancet.

[12]  Henrik Zetterberg,et al.  Plasma Aβ in Alzheimer's disease—up or down? , 2006, The Lancet Neurology.

[13]  Roberta F. White,et al.  The preclinical phase of alzheimer disease: A 22-year prospective study of the Framingham Cohort. , 2000, Archives of neurology.

[14]  J. Hardy,et al.  The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .

[15]  Richard Mayeux,et al.  Epidemiology of neurodegeneration. , 2003, Annual review of neuroscience.

[16]  K Yaffe,et al.  Midlife cardiovascular risk factors and risk of dementia in late life , 2005, Neurology.

[17]  G. Rose.  Sick individuals and sick populations. , 2001, International journal of epidemiology.

[18]  H. Braak,et al.  Neuropathology and Cognitive Impairment in Alzheimer Disease: A Complex but Coherent Relationship , 2009, Journal of neuropathology and experimental neurology.

[19]  R. Mayeux,et al.  Influence of education and occupation on the incidence of Alzheimer's disease. , 1994, JAMA.

[20]  L. Wolfson,et al.  Clinico‐pathologic studies in dementia , 1988, Neurology.